L-Carnitine for Male Infertility

Verdict: Improves sperm quality, not proven pregnancy

L-carnitine consistently improves sperm motility, morphology, and DNA integrity in men with idiopathic infertility, but it has not been shown to raise clinical pregnancy or live-birth rates. Treat it as a modest sperm-quality aid, not a proven fertility treatment.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This earns a Preliminary (B) grade because the evidence is consistent on surrogate markers but empty on outcomes that matter. Multiple systematic reviews and meta-analyses (PMID 35128424, PMID 34871624, PMID 40350672) agree that L-carnitine improves sperm motility by roughly 5 to 11 percent, along with morphology and DNA fragmentation. These findings are reproducible, but GRADE certainty was rated low to very low.

The gap is the clinical endpoint. The same reviews found no significant improvement in pregnancy: PMID 35128424 reported a pregnancy rate ratio of 1.03 (95% CI 0.54 to 1.96), and PMID 34871624 found 16.2% versus 11.2% (p=0.05, not significant). Live-birth data are largely absent, and most trials (including RCTs PMID 30873633 and PMID 35856361) used combination formulas, making it hard to credit L-carnitine alone.

Authorities are split and cautious. The FDA treats it only as a nutrient supplement, and EFSA rejected the claim that it supports normal sperm production. Mayo Clinic says the acetyl-L-carnitine combination did not raise sperm production or motility, and urology guidance finds the evidence too weak to recommend it; Cleveland Clinic is more favorable. A drug-interaction warning (warfarin, levothyroxine, valproate) also applies.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.65
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
78%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.46
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.85
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.647
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

Meta-analysis of the efficacy and safety of L-carnitine and N-acetylcysteine monotherapy for male idiopathic infertility
PMID: 40350672 2025 統合分析
Finding: L-carnitine improved sperm concentration (p<0.001), morphology (p=0.03), motility (p=0.02), and testosterone (p<0.001) vs placebo.
Government
View on PubMed
L-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility
PMID: 35128424 2020 系統性回顧 n = 459
Finding: Total motility +10.72% (95% CI 3.94–17.50, p<0.05); progressive motility +9.82% (p<0.05); morphology +2.41% (p<0.05); concentration NS; pregnancy rate RR 1.03 (95% CI 0.54–1.96, NS).
Academic Effect size: Total motility MD +10.72%; progressive motility MD +9.82%
View on PubMed
Systematic Review and Meta-analysis on Effect of Carnitine, Coenzyme Q10 and Selenium on Pregnancy and Semen Parameters in Couples With Idiopathic Male Infertility
PMID: 34871624 2022 系統性回顧 n = 827
Finding: Sperm motility MD +5.05 (p<0.0001), progressive motility MD +5.72 (p=0.0001), concentration MD +6.58 (p=0.0001) vs placebo; pregnancy rates 16.2% vs 11.2% (p=0.05, NS).
Effect size: Motility MD +5.05; concentration MD +6.58
View on PubMed
Double-blind, randomised, placebo-controlled trial on the effect of L-carnitine and L-acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia
PMID: 30873633 2019 RCT (double-blind) n = 175
Finding: Sperm volume, progressive motility, vitality significantly improved after 6 months (p<0.001); sperm DNA fragmentation index significantly decreased (p<0.001).
View on PubMed
Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial
PMID: 35856361 2022 RCT (open-label) n = 143
Finding: L-carnitine group showed significantly greater improvement in sperm concentration, progressive motility, and morphology vs CoQ10+Vit E group; LH increased only in L-carnitine group.
🟠 Limited quality
View on PubMed
L-Carnitine and Male Fertility: Is Supplementation Beneficial?
PMID: 37762736 2023 系統性回顧
Finding: Narrative review concludes L-carnitine positively impacts male fertility by enhancing sperm parameters and reducing oxidative stress; optimal dose not yet established.
🟠 Limited quality Government
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
膠囊狀、錠狀且標示有每日食用限量之食品,在每日食用量中,L-肉鹼(L-肉酸)總含量不得高於2克。特殊營養食品得視實際需要適量使用。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Against
studies didn't show increased sperm production and motility in men who took a combination of acetyl-L-carnitine and L-carnitine source↗
L5c Cleveland Clinic
Supportive
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-male-infertility-INT-l-carnitine-001 繁體中文版 →